Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Boehringer Ingelheim
Dow
Merck
Johnson and Johnson

Last Updated: August 19, 2022

Investigational Drug Information for GSK1278863


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for GSK1278863?

GSK1278863 is an investigational drug.

There have been 26 clinical trials for GSK1278863. The most recent clinical trial was a Phase 3 trial, which was initiated on August 8th 2016.

The most common disease conditions in clinical trials are Anemia, Kidney Diseases, and Renal Insufficiency, Chronic. The leading clinical trial sponsors are GlaxoSmithKline, PPD, and Octagon Research Solutions, Incoporated.

There are nine US patents protecting this investigational drug and one hundred and twenty-three international patents.

Recent Clinical Trials for GSK1278863
TitleSponsorPhase
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)GlaxoSmithKlinePhase 3
Absorption and Elimination of Radiolabeled DaprodustatGlaxoSmithKlinePhase 1
Daprodustat Hepatic Impairment StudyGlaxoSmithKlinePhase 1

See all GSK1278863 clinical trials

Clinical Trial Summary for GSK1278863

Top disease conditions for GSK1278863
Top clinical trial sponsors for GSK1278863

See all GSK1278863 clinical trials

US Patents for GSK1278863

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GSK1278863 See Plans and Pricing Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) See Plans and Pricing
GSK1278863 See Plans and Pricing Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators Pfizer Inc. (New York, NY) See Plans and Pricing
GSK1278863 See Plans and Pricing Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) See Plans and Pricing
GSK1278863 See Plans and Pricing Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators Pfizer Inc. (New York, NY) See Plans and Pricing
GSK1278863 See Plans and Pricing Bicyclic-fused heteroaryl or aryl compounds Pfizer Inc. (New York, NY) See Plans and Pricing
GSK1278863 See Plans and Pricing Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN) See Plans and Pricing
GSK1278863 See Plans and Pricing Bicyclic-fused heteroaryl or aryl compounds Pfizer Inc. (New York, NY) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for GSK1278863

Drugname Country Document Number Estimated Expiration Related US Patent
GSK1278863 Australia AU2017261372 2036-05-05 See Plans and Pricing
GSK1278863 Canada CA3023278 2036-05-05 See Plans and Pricing
GSK1278863 China CN107847398 2036-05-05 See Plans and Pricing
GSK1278863 European Patent Office EP3452003 2036-05-05 See Plans and Pricing
GSK1278863 European Patent Office EP3981392 2036-05-05 See Plans and Pricing
GSK1278863 Hong Kong HK1249728 2036-05-05 See Plans and Pricing
GSK1278863 Japan JP2019520866 2036-05-05 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Boehringer Ingelheim
Dow
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.